The North America medical collagen market growth is estimated to progress at a CAGR of 5.90% during the forecast period, 2022-2030, and generate a revenue of $366.69 million by 2030.

The well-established healthcare and the growing health awareness make the region a conducive market for collagens. Also, the consumption of collagen supplements in the form of foods and drinks is on the rise. The other growth driver includes the aging population that is increasingly vulnerable to age-related issues like arthritis.

To know more about this report, request a free sample copy

The North America medical collagen market growth analysis includes the assessment of the United States and Canada. In the United States, the sale of collagen-based products has increased, given their beneficial properties. Resultantly, there are growing demands for collagen supplements in the form of foods and beverages. Additionally, the geriatric population is on the rise. For instance, around 16.5% of the US population was 65 and above in 2019. The cells’ ability to produce natural collagen is decreased over time. As a result, the senior population is more likely to face issues related to skin and bones like wrinkled skin and arthritis.

Furthermore, the increasing clinical and experimental trials that indicate the beneficial effects of dietary supplements on skin health facilitate the collagen-based supplements market growth. At the same time, the US market witnesses the availability of counterfeit products and cheap substitutes despite being a lucrative market for health supplements. Accordingly, there is a growing need for stringent regulations in the market.

The North America medical collagen market segmentation includes product, source, and application. The application segment is further sub-divided into diagnostics, vascular grafts, wound care, cartilage repair, hemostats, bone grafts, tissue scaffolds, and other applications.

Bone graft is a process that includes surgery to rebuild damaged bones. Also, collagen is used in dentistry, since collagen fibers support gum tissues. Type I collagen, obtained from pigs and cows, is used by dentists in the grafting process. Collagen membrane is used for varied purposes, when the bone graft is placed in the wrong position or the bone around the tooth socket is diseased. As a result, the collagen membrane is used as a bone substitute.

In the case of tissue engineering, collagen scaffolds are used as a support structure to hasten cellular growth during the implantation process. This is also because collagen provides the structural and biological integrity and tissues, supplemented by collagen. Additionally, collage scaffolds are utilized because they entail specific properties like a porous structure, low immunogenicity, good permeability, etc., needed in scaffolds.

Moreover, collagen also has application in hemostats, wherein it aids in controlling the excess bleeding due to its absorbent properties. The collagen used is extracted from bovine-based collagen. It also helps in wound protection. The vastly hemostatic agent is the microfibrillar collagen hemostat (MCH), an absorbable collagen hemostat. Besides, it stimulates clot formation.

Some of the leading companies in the North America medical collagen market include Gelita, Jellagen, Italgel, Integra LifeSciences, etc.

Integra LifeSciences is a global leader in terms of medical technology. It caters to the medical and health industries. The company has manufacturing and research facilities in the Americas, the Middle East, Europe, Australia, and Asia, with headquarters in New Jersey, the US.

One of its key products, CUSA® Clarity, is part of CUSA® Tough Tissue Technology under neurosurgery, which offers enhanced performance to optimize the safe and quick debulking of fibrous tissues.

Report Synopsis:

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.